Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Nicholas A Saccomano

CEO, President at OnKure Therapeutics, Inc. (OKUR)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1K

Reported trades

Filed Stock Type Shares Price Value Since
Sep 23SEC OKUROnKure Therapeutics, Inc. Sell 8711,160 held (−1%) $2.97 $258 -29.3%
Jun 24SEC OKUROnKure Therapeutics, Inc. Sell 8611,247 held (−1%) $4.40 $378 -52.3%
Mar 24SEC OKUROnKure Therapeutics, Inc. Sell 867,333 held (−1%) $4.16 $358 -49.5%
Dec 23SEC OKUROnKure Therapeutics, Inc. Sell 877,419 held (−1%) $2.97 $258 -29.3%